ea0099p571 | Thyroid | ECE2024
Wang Xinpan
, Li Tiantian
, Li Yue
, Wang Qiuyi
, Cai Yun
, Wang Zhixiao
, Shi Yun
, Yang Tao
, Zheng Xuqin
Background: A subset of GravesÂ’ disease (GD) patients develops refractory hyperthyroidism, posing challenges in treatment decisions. The predictive value of baseline characteristics and early therapy indicators in identifying high risk individuals is an area worth exploration.Methods: A prospective cohort study (2018-2022) involved 597 newly diagnosed adult GD patients undergoing methimazole (MMI) treatment. Baseline characteristics and 3-month ther...